FDA weighs using tumor cell lines for vaccine development.
Vogel
G
G
D006801:Humans; D009369:Neoplasms / Q000209:etiology; D018570:Risk Assessment; D014407:Tumor Cells, Cultured; D014481:United States; D014486:United States Food and Drug Administration; D014612:Vaccines / Q000009:adverse effects / Q000096:biosynthesis*; D014765:Viral Vaccines / Q000096:biosynthesis
D014612:Vaccines; D014765:Viral Vaccines